seizures

The company's REMI product is currently FDA cleared for in-hospital use, but Epitel plans to expand into ambulatory and in-home care.

One of the great but nebulous promises of wearable health trackers is that, by monitoring something 24-7 that previously was only ever monitored intermittently, it will help us discover new things about our bodies and health.